Search
for
Sort by
Research 31–60 of 992
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Steroid Hormones
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- A Child with Nonscarring Alopecia
- Cutaneous drug reactions
- Hormone therapy in acne
- Lupus erythematosus: systemic and cutaneous manifestations
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Skin
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Targets to treat androgen excess in polycystic ovary syndrome
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Wound Healing: A Cellular Perspective
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Investigating drug induced alopecia
- Hyperadrenocorticism in Ferrets
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter.
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Repurposing of approved cardiovascular drugs
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19